Early Career Travel Stipend Award
Applications open October 5
The Early Career Travel Stipend Awards have been established to provide funding for deserving young investigators to attend the ASPHO Conference, present their work, and introduce them to the many benefits of ASPHO programming and networking. Up to five awards of $500 will be given per year.
The qualifications for the award candidates are as follows:
- Applicant is either currently a fellow in a pediatric hematology/oncology program or is within 4 years of completing a standard three-year pediatric hematology/oncology fellowship
- Applicant's abstract has been accepted for presentation either as a poster or paper at the ASPHO meeting
- Applicant submits an application for the award
- Applicant is currently a member of ASPHO (at the time of submission) living in the United States or Canada
- Applicant has not received any other ASPHO awards this year
- Past recipients of this award are not eligible
To apply, complete the application, including:
- A supporting letter from the training program director or the program chair, attesting to the applicant’s status as well as their role in the conduct of the abstract research project
- The letter should address the individual’s interest in the abstract topic area and how participation at the ASPHO Conference will advance this area of their career
Winners are chosen by evaluation of the abstract submitted for presentation at the ASPHO Conference, together with review of each candidate’s research contributions and application materials. The award consists of $500 and a certificate of recognition.
Notes:
- Abstract must be submitted no later than December 21, 2023 at 3pm CT
- All award application materials must be received no later than December 21, 2023 at 3 pm CT
- Selected by the Conference Planning Committee
To be considered for the award:
- Carefully review the criteria for the award to determine eligibility
- Complete the Award Application Form
- Include all required supplemental materials to make your award application complete
2023 Recipients
Alexandra Dreyzin, MD MS
Children's National Hospital
Washington, D.C.
CAREGIVERS’ PERSPECTIVE ON FAMILY LIFE DURING TREATMENT FOR B-ALL FROM THE CHILDREN’S ONCOLOGY
Paul George, MD
Children's Healthcare of Atlanta/Emory University
Atlanta, GA
ARE CHILDREN WITH SICKLE CELL DISEASE AT INCREASED RISK OF HARMS FROM AIR POLLUTION?
Brian Guedes, MD
Duke University
Durham, NC
CYCLIN-DEPENDENT KINASE 8 AS A NOVEL THERAPEUTIC TARGET IN FUSION-POSITIVE RHABDOMYOSARCOMA
Timothy J.D. Ohlsen, MD
Seattle Children's Hospital
Seattle, WA
ANTIMICROBIAL LOCKS FOR CLABSI PREVENTION IN THE INPATIENT SETTING: A COST-EFFECTIVENESS ANALYSIS
Rocio Rivera-Valentin, MD
Nemours Children's Health, Jacksonville and University of Florida, Jacksonville
Jacksonville, FL
A NOVEL PD-1 SWITCH RECEPTOR CAR T-CELL THERAPY TARGETS DIFFUSE INTRINSIC PONTINE GLIOMA
Past Recipients
2022 Eman Al-Antary, MD
Sharmila Raghunandan, DO MPH
Connor Hall, MD PhD
Roma Rajput, MD
Sherri Smart, MD PhD
2021 Holly Edington, MD
Nura El-Haj, MD
Diana Fridlyand, MD
Sumit Gupta, MD
Peter Schoettler, MD
2020 Harry Lesmana, MD FAAP FACMG
Lisa Maurer, MD PhD
Mallery Olsen, MD
Anthony Sabulski, MD
Ryan Summers, MD
2019 Nathan A. Dahl, MD
Claudia Zapata, MD
Jeremy Rubinstein, MD PhD
Matthew Dietz, DO, MSEd
Regina M. Myers, MD
2018 Amy Houghtelin, MD
Zachary LeBlanc, MD
Joseph H. Oved, MD MA
Allison Remiker, MD
Luke R. Smart, MD
2017 Jason Schwartz, MD PhD
Ryan J. Summers, MD
Michael Deel, MD
2016 Waitman Aumann, MD
Jonathan Marron, MD
Pillai Pallavi Madhusoodhan, MD
Nickhill Bhakta, MD